Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Liraglutide
Related studies linked through entity extraction aliases.
Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy
- Status
- COMPLETED
- Phase
- PHASE2
Liraglutide and Peripheral Artery Disease
- Status
- COMPLETED
- Phase
- PHASE4
The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
- Status
- COMPLETED
- Phase
- NA
SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
- Status
- RECRUITING
- Phase
- PHASE4
Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities
- Status
- UNKNOWN
- Phase
- PHASE3
Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Tirzepatide in Overweight and Very Overweight Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide
- Status
- UNKNOWN
- Phase
- NA
Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet
- Status
- UNKNOWN
- Phase
- PHASE4
Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity
- Status
- COMPLETED
- Phase
- PHASE3
A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
- Status
- COMPLETED
- Phase
- N/A
Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
- Status
- UNKNOWN
- Phase
- NA
Replication of the LEADER Diabetes Trial in Healthcare Claims
- Status
- COMPLETED
- Phase
- N/A